MONCTON, NEW BRUNSWICK–(Marketwired – Aug. 31, 2017) – Organigram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) is pleased to announce the release of a new addition to its cannabis oil offerings: a pure CBD edible oil, Shubie. This pure CBD product is a first for Organigram, complementing the company’s existing line of medical cannabis oil products.
Cannabinoids are the chemical compounds unique to cannabis that act upon the human body’s cannabinoid receptors. There are over 80 known cannabinoids present in the cannabis plant, each with varying effects. CBD (or Cannabidiol) is the second most prevalent cannabinoid in cannabis. Research has shown that CBD provides a therapeutic or calming effect without contributing to the “high” associated with Tetrahydrocannabinol (or THC), the psychoactive compound in cannabis.i
“Patients are unique and require different products that help in different ways” says